First Time Loading...

Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 5.85 USD -1.68% Market Closed
Updated: May 7, 2024

Wall Street
Price Targets

CLGN Price Targets Summary
Collplant Biotechnologies Ltd

Wall Street analysts forecast CLGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLGN is 11.22 USD with a low forecast of 11.11 USD and a high forecast of 11.55 USD.

Lowest
Price Target
11.11 USD
90% Upside
Average
Price Target
11.22 USD
92% Upside
Highest
Price Target
11.55 USD
97% Upside
Collplant Biotechnologies Ltd Competitors:
Price Targets
ARQT
Arcutis Biotherapeutics Inc
131% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
69% Upside
9969
InnoCare Pharma Ltd
53% Upside
302440
SK Bioscience Co Ltd
5% Downside
TNGX
Tango Therapeutics Inc
127% Upside
MDXG
MiMedx Group Inc
79% Upside
RXRX
Recursion Pharmaceuticals Inc
48% Upside
4587
PeptiDream Inc
42% Upside

Revenue
Forecast

Revenue Estimate
Collplant Biotechnologies Ltd

For the last 4 years the compound annual growth rate for Collplant Biotechnologies Ltd's revenue is 47%. The projected CAGR for the next 3 years is 97%.

47%
Past Growth
97%
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Collplant Biotechnologies Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Net Income
Forecast

Net Income Estimate
Collplant Biotechnologies Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLGN's stock price target?
Price Target
11.22 USD

According to Wall Street analysts, the average 1-year price target for CLGN is 11.22 USD with a low forecast of 11.11 USD and a high forecast of 11.55 USD.

What is Collplant Biotechnologies Ltd's Revenue forecast?
Projected CAGR
97%

For the last 4 years the compound annual growth rate for Collplant Biotechnologies Ltd's revenue is 47%. The projected CAGR for the next 3 years is 97%.